Metabolic reprogramming by histone deacetylase inhibition preferentially targets NRF2-activated tumors
Karagiannis D, Wu W, Li A, Hayashi M, Chen X, Yip M, Mangipudy V, Xu X, Sánchez-Rivera FJ, Soto-Feliciano YM, Ye J, Papagiannakopoulos T, Lu C.
Cell Rep. 2024 Jan 23;43(1):113629. doi: 10.1016/j.celrep.2023.113629. Epub 2023 Dec 30. PMID: 38165806
